Session Information
AABB Annual Meeting and CTTXPO 2010
Click here to go to the previous page
Transfusion-Transmitted Diseases: Retroviruses
Track
:
Oral Abstracts
Program Code:
010A
Date:
Saturday, October 9, 2010
Time:
4:00 PM to 5:30 PM
EST
Location:
337/338
MODERATOR
(S):
Eberhard Fiebig, MD, San Francisco General Hospital
Michael Busch, MD, PhD, Senior Vice President, Research & Scientific Affairs, BSI; & Director, BSRI, Blood Systems, Inc.; & Blood Systems Research Institute
Description
OBJECTIVES:
- Appraise new findings in HIV blood donor testing, including the distribution of HIV viral loads in clade B vs. clade C infections, the residual risk of HIV transmission in Brazil, and false positive rates by Abbott’s HIV O plus assay.
- Judge the feasibility of maintaining a “2 hit” donor management policy using the PRISM Anti-HTLV-I/II screening assay.
- Discuss the findings of absence of detectable xenotropic Murine Leukemia Virus (XMRV) in samples from HIV-1 infected individuals in Africa and performance of a new serological test for XMRV in the context of potential transmissibility of this virus by transfusion.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |